$CATX
Perspective Therapeutics Inc Stock $catx

$catx Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000143774919009498 Filed on May 10, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$1.924M	$1.924M	$1.573M
YoY Change	20.02%	22.31%	22.7%
Cost Of Revenue	$1.045M	$1.045M	$964.0K
YoY Change	-10.68%	8.4%	-2.53%
Gross Profit	$879.0K	$879.0K	$609.0K
YoY Change	98.42%	44.33%	107.85%
Gross Profit Margin	45.69%	45.69%	38.72%
Selling, General & Admin	$1.682M	$1.744M	$1.475M
YoY Change	-24.91%	18.24%	8.86%
% of Gross Profit	191.35%	198.41%	242.2%
Research & Development	$341.0K	$299.0K	$473.0K
YoY Change	-40.18%	-36.79%	44.65%
% of Gross Profit	38.79%	34.02%	77.67%
Depreciation & Amortization	$49.00K	$47.00K	$30.00K
YoY Change	63.33%	56.67%	-25.0%
% of Gross Profit	5.57%	5.35%	4.93%
Operating Expenses	$2.023M	$2.042M	$1.948M
YoY Change	-27.75%	4.83%	15.81%
Operating Profit	-$1.144M	-$1.163M	-$1.339M
YoY Change	-51.46%	-13.14%	-3.6%
Interest Expense	$49.00K	$34.00K	$10.00K
YoY Change	390.0%	240.0%	-66.67%
% of Operating Profit
Other Income/Expense, Net	$0.00	$36.00K	$7.000K
YoY Change		414.29%	-75.86%
Pretax Income	-$1.095M	-$1.127M	-$1.330M
YoY Change	-53.6%	-15.26%	-2.21%
Income Tax
% Of Pretax Income
Net Earnings	-$1.095M	-$1.127M	-$1.332M
YoY Change	-53.27%	-15.39%	-2.06%
Net Earnings / Revenue	-56.91%	-58.58%	-84.68%
Basic Earnings Per Share
Diluted Earnings Per Share	-$16.26K	-$16.74K	-$24.14K
COMMON SHARES
Basic Shares Outstanding	67.34M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.326M	$6.392M	$4.520M
YoY Change	55.28%	41.42%	-56.58%
Cash & Equivalents	$5.326M	$4.059M	$2.365M
Short-Term Investments	$0.00	$2.333M	$2.150M
Other Short-Term Assets	$27.00K	$390.0K	$380.0K
YoY Change	-6.9%	2.63%	8.57%
Inventory	$530.0K	$533.0K	$458.0K
Prepaid Expenses
Receivables	$1.154M	$1.116M	$970.0K
Other Receivables	$86.00K	$0.00	$0.00
Total Short-Term Assets	$7.315M	$8.431M	$6.325M
YoY Change	34.32%	33.3%	-46.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.609M	$1.564M	$1.229M
YoY Change	22.73%	27.26%	21.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$162.0K	$160.0K	$192.0K
YoY Change	-18.18%	-16.67%	-28.09%
Total Long-Term Assets	$2.107M	$2.148M	$1.997M
YoY Change	4.88%	7.56%	-1.04%
TOTAL ASSETS
Total Short-Term Assets	$7.315M	$8.431M	$6.325M
Total Long-Term Assets	$2.107M	$2.148M	$1.997M
Total Assets	$9.422M	$10.58M	$8.322M
YoY Change	26.38%	27.12%	-40.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$683.0K	$1.001M	$770.0K
YoY Change	-50.86%	30.0%	8.45%
Accrued Expenses	$438.0K	$354.0K	$350.0K
YoY Change	-0.45%	1.14%	-18.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.121M	$1.355M	$1.123M
YoY Change	-38.91%	20.66%	-1.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$621.0K	$613.0K	$580.0K
YoY Change	5.25%	5.69%	5.45%
Total Long-Term Liabilities	$621.0K	$613.0K	$580.0K
YoY Change	5.25%	5.69%	5.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.121M	$1.355M	$1.123M
Total Long-Term Liabilities	$621.0K	$613.0K	$580.0K
Total Liabilities	$1.742M	$1.968M	$1.706M
YoY Change	-28.16%	15.36%	0.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.49M	-$83.40M	-$76.95M
YoY Change	6.48%	8.38%	8.76%
Common Stock	$92.17M	$92.01M	$83.56M
YoY Change	9.24%	10.11%	0.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.680M	$8.611M	$6.616M
YoY Change
Total Liabilities & Shareholders Equity	$9.422M	$10.58M	$8.322M
YoY Change	26.38%	27.12%	-40.31%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$1.095M	-$1.127M	-$1.332M
YoY Change	-53.27%	-15.39%	-2.06%
Depreciation, Depletion And Amortization	$49.00K	$47.00K	$30.00K
YoY Change	63.33%	56.67%	-25.0%
Cash From Operating Activities	-$985.0K	-$1.338M	-$1.080M
YoY Change	-32.07%	23.89%	-27.52%
INVESTING ACTIVITIES
Capital Expenditures	-$105.0K	-$128.0K	-$80.00K
YoY Change	-19.23%	60.0%	60.0%
Acquisitions
YoY Change
Other Investing Activities	$2.344M	$2.333M	$580.0K
YoY Change	77.58%	302.24%	-2033.33%
Cash From Investing Activities	$2.239M	$2.205M	$500.0K
YoY Change	86.58%	341.0%	-725.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.00K	-9.000K	0.000
YoY Change	-97.29%
NET CHANGE
Cash From Operating Activities	-985.0K	-1.338M	-1.080M
Cash From Investing Activities	2.239M	2.205M	500.0K
Cash From Financing Activities	13.00K	-9.000K	0.000
Net Change In Cash	1.267M	858.0K	-580.0K
YoY Change	450.87%	-247.93%	-63.06%
FREE CASH FLOW
Cash From Operating Activities	-$985.0K	-$1.338M	-$1.080M
Capital Expenditures	-$105.0K	-$128.0K	-$80.00K
Free Cash Flow	-$880.0K	-$1.210M	-$1.000M
YoY Change	-33.33%	21.0%	-30.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	67338047
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Registrant Name EntityRegistrantName	IsoRay, Inc.
	dei	Trading Symbol TradingSymbol	isr
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Central Index Key EntityCentralIndexKey	0000728387
CY2017Q4	isr	Adjustments To Additional Paid In Capital Sharebased Compensation Third Party Services AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationThirdPartyServices	72000
	isr	Noncash Financing Activities Warrants Issued NoncashFinancingActivitiesWarrantsIssued	163000
CY2019Q1	isr	Research And Development Collaboration Services Net Of Reimbursement ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
CY2018Q1	isr	Research And Development Collaboration Services Net Of Reimbursement ResearchAndDevelopmentCollaborationServicesNetOfReimbursement	156000
	isr	Noncash Financing Activities Warrants Issued NoncashFinancingActivitiesWarrantsIssued
CY2015Q4	isr	Purchase Agreement Period PurchaseAgreementPeriod	P1Y
	isr	Research And Development Proprietary Research And Development ResearchAndDevelopmentProprietaryResearchAndDevelopment	914000
	isr	Research And Development Collaboration Services Net Of Reimbursement ResearchAndDevelopmentCollaborationServicesNetOfReimbursement	45000
	isr	Research And Development Collaboration Services Net Of Reimbursement ResearchAndDevelopmentCollaborationServicesNetOfReimbursement	260000
CY2019Q1	isr	Research And Development Proprietary Research And Development ResearchAndDevelopmentProprietaryResearchAndDevelopment	299000
CY2018Q1	isr	Research And Development Proprietary Research And Development ResearchAndDevelopmentProprietaryResearchAndDevelopment	317000
	isr	Research And Development Proprietary Research And Development ResearchAndDevelopmentProprietaryResearchAndDevelopment	1088000
CY2019Q1	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	7000
CY2018Q1	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	5000
	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	94000
	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	38000
CY2019Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1001000
CY2018Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1391000
CY2019Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	117000
CY2018Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	77000
CY2019Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	134000
CY2018Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	175000
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7334000
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7671000
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	91941000
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	84322000
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	37000
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	37000
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	93000
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	97000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	79000
CY2017Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	90000
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78000
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	77000
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	116000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	8000
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	79000
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	77000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	269000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	245000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10064000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3581000
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	23000
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	22000
CY2019Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	613000
CY2018Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	590000
CY2019Q1	us-gaap	Assets Assets	10579000
CY2018Q2	us-gaap	Assets Assets	7455000
CY2019Q1	us-gaap	Assets Current AssetsCurrent	8431000
CY2018Q2	us-gaap	Assets Current AssetsCurrent	5446000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4059000
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2600000
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2365000
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2781000
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6113000
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4240000
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2546000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1459000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3567000
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5830000
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67338047
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56331147
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67338047
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56331147
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	67000
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	56000
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1045000
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	964000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3222000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2915000
	us-gaap	Depreciation Depreciation	100000
	us-gaap	Depreciation Depreciation	56000
CY2018Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	11000
CY2017Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	11000
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38000
CY2018Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	155000
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	494000
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P346D
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
CY2019Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000
CY2018Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1099000
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	783000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	24000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3173000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2610000
CY2019Q1	us-gaap	Gross Profit GrossProfit	879000
CY2018Q1	us-gaap	Gross Profit GrossProfit	609000
	us-gaap	Gross Profit GrossProfit	2168000
	us-gaap	Gross Profit GrossProfit	1405000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-390000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	96000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-76000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	250000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-117000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-33000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-37000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16000
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	40000
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	2000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	28000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-97000
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-41000
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	2000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	53000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58000
CY2019Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	36000
CY2018Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	27000
CY2019Q1	us-gaap	Inventory Net InventoryNet	533000
CY2018Q2	us-gaap	Inventory Net InventoryNet	494000
CY2019Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	243000
CY2018Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	319000
CY2019Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	383000
CY2018Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	371000
CY2019Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	114000
CY2018Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	96000
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	34000
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	59000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	17000
CY2019Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	65000
CY2019Q1	us-gaap	Liabilities Liabilities	1968000
CY2018Q2	us-gaap	Liabilities Liabilities	2425000
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10579000
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7455000
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1355000
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1835000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7361000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	39000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1838000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	658000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4064000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4264000
	us-gaap	Net Income Loss NetIncomeLoss	-4049000
	us-gaap	Net Income Loss NetIncomeLoss	-4342000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-1127000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-1332000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-1508000
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-1414000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-1546000
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-1464000
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1130000
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1335000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4057000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4350000
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	36000
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	61000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17000
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	2042000
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	1948000
	us-gaap	Operating Expenses OperatingExpenses	6278000
	us-gaap	Operating Expenses OperatingExpenses	5764000
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1163000
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1339000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4110000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4359000
CY2018Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	37000
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	160000
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	198000
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11000
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	353000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	231000
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	11141000
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	4054000
CY2019Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3000
CY2018Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3000
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8000
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8000
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	390000
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	335000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7370000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	24000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9632000
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4943000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	50000
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8898000
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8982000
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1564000
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1311000
CY2019Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	1116000
CY2018Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	1192000
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	299000
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	473000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1133000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1174000
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000
CY2018Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-83397000
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79348000
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1924000
CY2018Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1573000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5390000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4320000
CY2018Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	692000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1996000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1980000
	us-gaap	Share Based Compensation ShareBasedCompensation	269000
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	645000
	us-gaap	Share Based Compensation ShareBasedCompensation	317000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2163000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.79
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	10000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	20000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	37500
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	70750
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	114041
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	25000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	15000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	262500
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	90000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3925000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.67
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	10000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	10000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3925000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.67
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y65D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y310D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y65D
CY2019Q1	us-gaap	Short Term Investments ShortTermInvestments	2333000
CY2018Q2	us-gaap	Short Term Investments ShortTermInvestments	825000
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6900
CY2018Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6900
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	82810
CY2018Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7494000
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000
CY2017Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	8611000
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	5030000
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	11109000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	9665000
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	10602000
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	9146000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	7871000
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	6616000
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67333000
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55100000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	66937000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55058000

Files In Submission

Name	View Source	Status
0001437749-19-009498-index-headers.html	Edgar Link	pending
0001437749-19-009498-index.html	Edgar Link	pending
0001437749-19-009498.txt	Edgar Link	pending
0001437749-19-009498-xbrl.zip	Edgar Link	pending
ex_143069.htm	Edgar Link	pending
ex_143070.htm	Edgar Link	pending
ex_143071.htm	Edgar Link	pending
ex_143072.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
isr-20190331.xml	Edgar Link	completed
isr-20190331.xsd	Edgar Link	pending
isr-20190331_cal.xml	Edgar Link	unprocessable
isr-20190331_def.xml	Edgar Link	unprocessable
isr-20190331_lab.xml	Edgar Link	unprocessable
isr-20190331_pre.xml	Edgar Link	unprocessable
isr20190630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CATX
Perspective Therapeutics Inc Stock $catx

2019 Q2 Form 10-Q Financial Statement

#000143774919009498 Filed on May 10, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX Perspective Therapeutics Inc Stock $catx

2019 Q2 Form 10-Q Financial Statement

#000143774919009498 Filed on May 10, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX
Perspective Therapeutics Inc Stock $catx